A

Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408

Watchlist Manager
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Watchlist
Price: 12.64 CNY -5.81% Market Closed
Market Cap: 5.1B CNY
Have any thoughts about
Anhui Huaren Health Pharmaceutical Co Ltd?
Write Note

Gross Margin
Anhui Huaren Health Pharmaceutical Co Ltd

30.4%
Current
31%
Average
32.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.4%
=
Gross Profit
1.2B
/
Revenue
4.1B

Gross Margin Across Competitors

Country CN
Market Cap 5.1B CNY
Gross Margin
30%
Country ZA
Market Cap 94.9B Zac
Gross Margin
23%
Country ZA
Market Cap 33.4B Zac
Gross Margin
23%
Country US
Market Cap 7.7B USD
Gross Margin
18%
Country BR
Market Cap 44.1B BRL
Gross Margin
30%
Country JP
Market Cap 862.9B JPY
Gross Margin
35%
Country SA
Market Cap 16.8B SAR
Gross Margin
39%
Country CN
Market Cap 30.3B CNY
Gross Margin
38%
Country MX
Market Cap 81.1B MXN
Gross Margin
23%
Country JP
Market Cap 556B JPY
Gross Margin
20%
Country NL
Market Cap 3.2B EUR
Gross Margin
23%

Profitability Report

View the profitability report to see the full profitability analysis for Anhui Huaren Health Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.4%
=
Gross Profit
1.2B
/
Revenue
4.1B
What is the Gross Margin of Anhui Huaren Health Pharmaceutical Co Ltd?

Based on Anhui Huaren Health Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 30.4%.